Instrumento Inactivo

Acciones Kun Run Biotechnology, Inc.

Acciones

Duración

Período

Estilo

KUN RUN BIOTCH : Kun Run Biotechnology Announces That They Have Obtained the Manufacturing Approval for Entecavir from the China State Food and Drug Administration	17/06/10
KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Executes Purchase Agreements for Approximately $8 Million Private Placement	22/04/10
KUN RUN BIOTCH : Kun Run Biotechnology Reports Fourth Quarter and Fiscal Year 2009 Financial Results	30/03/10
KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results	13/11/09
KUN RUN BIOTECHNLG : Kun Run Biotechnology, Inc. Year-End Revenues Increase 56% to $11.6 million	01/04/09

Sector

	Varia. 1 de ene.	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19,62 %	43,34 mil M
OTSUKA HOLDINGS CO., LTD.	+20,44 %	21,96 mil M
SANDOZ GROUP AG	+10,86 %	14,09 mil M
CIPLA LIMITED	+13,07 %	13,64 mil M
ZYDUS LIFESCIENCES LIMITED	+37,46 %	11,43 mil M
ONO PHARMACEUTICAL CO., LTD.	-8,59 %	6863,13 M
THE MEDICINES COMPANY	-0,05 %	6787,61 M
STADA ARZNEIMITTEL	-8,87 %	5725,52 M
ASPEN PHARMACARE HOLDINGS LIMITED	+8,46 %	5216,04 M